NovoCure Ltd (NASDAQ:NVCR)’s traded shares stood at 1.39 million during the last session, with the company’s beta value hitting 0.50. At the close of trading, the stock’s price was $12.05. The NVCR share’s 52-week high remains $83.60, putting it -593.78% down since that peak but still an impressive 9.79% since price per share fell to its 52-week low of $10.87. The company has a valuation of $1.29B, with an average of 1.38 million shares over the past 3 months.

NovoCure Ltd (NASDAQ:NVCR) trade information

NovoCure Ltd (NVCR) has traded red over the past five days. The stock hit a weekly high of 14.12. The 5-day price performance for the stock is -14.66%, and -11.00% over 30 days. With these gigs, the year-to-date price performance is -19.29%.

NovoCure Ltd (NVCR) estimates and forecasts

Looking at statistics comparing NovoCure Ltd share performance against respective industry, we note that the company has underperformed competitors. NovoCure Ltd (NVCR) shares are -22.90% down over the last 6 months, with its year-to-date growth rate lower than industry average at 8.72% against 12.80%.

NVCR Dividends

NovoCure Ltd has its next earnings report out on May 02. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. NovoCure Ltd has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.